Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Drugs for Treatment of Ulcerative Colitis in IBD01:29

Drugs for Treatment of Ulcerative Colitis in IBD

343
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
343
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents01:29

Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents

364
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
364
Inflammatory Bowel Disease IV: Pharmacological Management01:29

Inflammatory Bowel Disease IV: Pharmacological Management

341
Upon diagnosis, managing Inflammatory Bowel Disease (IBD) involves addressing several crucial aspects. The primary goals include resting the bowel, correcting malnutrition, and providing symptomatic relief. Resting the bowel may consist of medications to reduce inflammation and promote healing. Correcting malnutrition is essential, often requiring dietary adjustments and nutritional supplements. Symptomatic relief aims to ease pain, diarrhea, and other discomforts in IBD.
Pharmacologic...
341
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids01:21

Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids

328
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
328

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

An updated patent review of dual-specificity tyrosine phosphorylation-regulated kinase 1A (DYRK1A) inhibitors (2020-present).

Expert opinion on therapeutic patents·2026
Same author

Structure-Based Design, Synthesis, and Evaluation of Novel Ponatinib Derivatives With a Significantly Altered Selectivity Profile.

ChemMedChem·2026
Same author

Seeding the Spine: Salmonella Java Discitis and Osteomyelitis After Traveller's Bacteraemia.

Cureus·2026
Same author

Coexisting ADAR and TSHB Mutations in an Infant With Retinal Detachment and Transient Cardiomyopathy.

Case reports in endocrinology·2026
Same author

Student engagement profiles in a mobile app: Links to self-regulated learning and performance.

Educational technology research and development : ETR & D·2026
Same author

Benzothiophene nucleus in target-directed anti-cancer drug discovery.

European journal of medicinal chemistry·2026
Same journal

Liquiritigenin ameliorates adipocyte insulin resistance by inhibiting pro-inflammatory polarization of macrophages via regulation of the mtROS/OXPHOS axis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same journal

Corrigendum to "Quercetin attenuates chondrocyte anoikis via modulation of mesenchymal stromal cell-derived small extracellular vesicles to promote cartilage repair in osteoarthritis" [Phytomedicine 146 (2025) 157146].

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same journal

Therapeutic potential of scutellarin in central nervous system: A comprehensive review.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same journal

CHPF2-driven chondroitin sulfation of Wnt1 promotes colorectal cancer progression and is targeted by ponicidin.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same journal

Xuefu Zhuyu Decoction Ameliorates Neuroinflammation after Traumatic Brain Injury via tRF-3-Leu-AAG/Gpr17 axis.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
Same journal

Fangchinoline alleviates atypical hyperplasia of metaplastic ducts and pancreatic fibrosis in caerulein-induced mice.

Phytomedicine : international journal of phytotherapy and phytopharmacology·2026
See all related articles

Related Experiment Video

Updated: Dec 13, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

3.0K

Menthacarin attenuates experimental colitis.

Korina Alliger1, Mohammad Khalil2, Beatrix König3

  • 1Department of Medicine 1, Universitätsklinikum Erlangen, Ulmenweg 18, 91054 Erlangen, Germany.

Phytomedicine : International Journal of Phytotherapy and Phytopharmacology
|July 26, 2020
PubMed
Summary
This summary is machine-generated.

Menthacarin, a blend of peppermint and caraway oils, reduced inflammation and improved symptoms in a mouse model of colitis. This natural compound shows potential as an add-on therapy for inflammatory bowel disease (IBD).

Keywords:
CarawayInflammatory bowel diseaseMenthacarinPeppermintTRPA1TRPM8

More Related Videos

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.3K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

1.1K

Related Experiment Videos

Last Updated: Dec 13, 2025

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice
07:34

Induction of Intestinal Inflammation by Adoptive Transfer of CBir1 TCR Transgenic CD4+ T Cells to Immunodeficient Mice

Published on: December 16, 2021

3.0K
DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat
09:04

DNBS/TNBS Colitis Models: Providing Insights Into Inflammatory Bowel Disease and Effects of Dietary Fat

Published on: February 27, 2014

48.3K
Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation
08:34

Investigating the Alleviating Effects of Bacillus cereus Administration on Colitis through Gut Microbiota Modulation

Published on: July 27, 2022

1.1K

Area of Science:

  • Gastroenterology
  • Pharmacology
  • Immunology

Background:

  • Peppermint oil and caraway oil are recognized for their spasmolytic and analgesic properties in gastrointestinal medicine.
  • These natural remedies have a history of use in managing digestive discomfort.

Purpose of the Study:

  • To evaluate the anti-inflammatory effects of Menthacarin, a combination of peppermint and caraway oils.
  • To assess Menthacarin's efficacy in a dextran sodium sulfate (DSS)-induced murine model of colitis.

Main Methods:

  • C57BL/6 mice were administered varying doses of Menthacarin (10-120 µg/g BW) or a control (0.2% agar).
  • DSS-induced colitis was maintained for 8 days, with monitoring of body weight and colonoscopy.
  • Colonic tissues were analyzed histologically, and key cytokines (TNFα, IL-6, IL-10, IL-1β, TGF-β) were quantified via ELISA.

Main Results:

  • Menthacarin treatment led to improved macroscopic and microscopic colitis parameters compared to controls.
  • Mice receiving Menthacarin exhibited reduced body weight loss during the experimental period.
  • The colonic cytokine profile shifted towards a regulatory and anti-inflammatory phenotype in Menthacarin-treated mice.

Conclusions:

  • Menthacarin effectively attenuates experimental colitis in a murine model.
  • The findings suggest Menthacarin holds promise as a complementary therapy for inflammatory bowel disease (IBD).